Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -84.93% is 38% above its 5-year average of -136.25%, near the high end of its 5-year range (-568.30%–-69.42%).
5.38% above its 12-month average of -89.76%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -89.42%.
NET PROFIT MARGIN
-84.93%
NET PROFIT MARGIN AVG TTM
-89.76%
NET PROFIT MARGIN AVG 3Y
-94.66%
NET PROFIT MARGIN AVG 5Y
-136.25%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+5.38%
CURRENT VS 3Y AVG
+10.28%
CURRENT VS 5Y AVG
+37.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CVRx, Inc.
Market Cap
$44.32M
Net Profit Margin
-84.93%
TTM Avg
-89.76%
3Y Avg
-94.66%
5Y Avg
-136.25%
Market Cap
$44.41M
Net Profit Margin
-145.56%
TTM Avg
-153.73%
3Y Avg
-223.84%
5Y Avg
-240.41%
Market Cap
$43.78M
Net Profit Margin
-747.20%
TTM Avg
-525.22%
3Y Avg
-722.73%
5Y Avg
-1271.67%
Market Cap
$43.65M
Net Profit Margin
-13.86%
TTM Avg
-1.65%
3Y Avg
-39.69%
5Y Avg
-47.80%
Market Cap
$43.51M
Net Profit Margin
32.60%
TTM Avg
-34.66%
3Y Avg
-64.33%
5Y Avg
-204.90%
Market Cap
$45.41M
Net Profit Margin
-164.82%
TTM Avg
-1870.42%
3Y Avg
-1064.08%
5Y Avg
-709.38%
Market Cap
$45.92M
Net Profit Margin
322.77%
TTM Avg
-172.32%
3Y Avg
-215.38%
5Y Avg
-270.73%
Market Cap
$41.92M
Net Profit Margin
-4.42%
TTM Avg
-14.19%
3Y Avg
-49.13%
5Y Avg
-77.93%
Market Cap
$47.83M
Net Profit Margin
-11.51%
TTM Avg
-20.89%
3Y Avg
-14.48%
5Y Avg
-10.80%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.32M | -84.93% | -89.76% | -94.66% | -136.25% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.41M | -145.56% | -153.73% | -223.84% | -240.41% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.78M | -747.20% | -525.22% | -722.73% | -1271.67% |
| BioStem Technologies, Inc. (BSEM)vs › | $43.65M | -13.86% | -1.65% | -39.69% | -47.80% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.51M | 32.60% | -34.66% | -64.33% | -204.90% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.41M | -164.82% | -1870.42% | -1064.08% | -709.38% |
| DarioHealth Corp. (DRIO)vs › | $45.92M | 322.77% | -172.32% | -215.38% | -270.73% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -4.42% | -14.19% | -49.13% | -77.93% |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | -11.51% | -20.89% | -14.48% | -10.80% |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.22M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-90.5%
Net Profit Margin
-84.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -89.42% |
| 2026-03-31 | -88.83% |
| 2025-12-31 | -74.48% |
| 2025-09-30 | -87.61% |
| 2025-06-30 | -108.44% |
| 2025-03-31 | -111.48% |
| 2024-12-31 | -69.42% |
| 2024-09-30 | -97.95% |
| 2024-06-30 | -118.82% |
| 2024-03-31 | -206.00% |
| 2023-12-31 | -81.05% |
| 2023-09-30 | -85.73% |
| 2023-06-30 | -122.64% |
| 2023-03-31 | -142.55% |
| 2022-12-31 | -146.82% |
| 2022-09-30 | -158.91% |
| 2022-06-30 | -220.06% |
| 2022-03-31 | -245.12% |
| 2021-12-31 | -288.96% |
| 2021-09-30 | -180.65% |
| 2021-06-30 | -568.30% |
| 2021-03-31 | -301.64% |
| 2020-12-31 | -162.93% |
| 2020-09-30 | -323.67% |
| 2020-06-30 | -293.36% |
| 2020-03-31 | -221.94% |
